Results 131 to 140 of about 58,659 (191)

Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa. [PDF]

Microb Genom, 2022
Oostvogels S, Ley SD, Heupink TH, Dippenaar A, Streicher EM, De Vos E, Meehan CJ, Dheda K, Warren R, Van Rie A.   +9 more
europepmc   +1 more source

Cerebral Tuberculoma in a Patient With Pre-extensively Drug-Resistant Tuberculosis and AIDS: Diagnostic and Management Challenges. [PDF]

Cureus
Mkrtchyan S.
europepmc   +1 more source

A systematic review on extensively drug-resistant tuberculosis from 2009 to 2020: special emphases on treatment outcomes. [PDF]

Rev Esp Quimioter, 2023
Shiromwar SS, Khan AH, Chidrawar V.
europepmc   +1 more source

Extensively Drug-Resistant Tuberculosis With Treatment-Limiting Mood Disorder: A Case of Complex Regimen Selection and Mental Health Challenges. [PDF]

Cureus
Mkrtchyan S.
europepmc   +1 more source

Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009

Emerging Infectious Diseases, 2012
Dawei Shi, Hui Li, Yuling Zhao, Qiong Jia, Christopher Coulter, Liang Li, Guofeng Zhu   +6 more
doaj   +1 more source

Interim efficacy and safety analysis of the regimen containing delamanid in the treatment of multidrug resistant/rifampicin-resistant/extensively drug-resistant tuberculosis: a single-arm, prospective, monocentric, observational study. [PDF]

BMC Infect Dis
Qin Y, Chen Y, Cai Q.
europepmc   +1 more source

Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review. [PDF]

Infect Drug Resist, 2021
Varshney K, Anaele B, Molaei M, Frasso R, Maio V.   +4 more
europepmc   +1 more source

Treatment outcomes of patients with multidrug and extensively drug-resistant tuberculosis in Zhejiang, China. [PDF]

Eur J Med Res, 2021
Zhang MW, Zhou L, Zhang Y, Chen B, Peng Y, Wang F, Liu ZW, Wang XM, Chen SH.   +8 more
europepmc   +1 more source

Comprehensive genomic surveillance reveals transmission profiles of extensively drug-resistant tuberculosis cases in Pará, Brazil. [PDF]

Front Microbiol
Marcon DJ, Sharma A, Souza AB, Barros RB, Andrade VDGD, Guimarães RJPS, Lima LNG, Monteiro LHMT, Quaresma AJPG, Ribeiro LR, Suffys PN, Warren RM, Alberio CAA, Lima KVB, Conceição EC.   +14 more
europepmc   +1 more source

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines. [PDF]

BMJ Open, 2021
Gomez GB, Siapka M, Conradie F, Ndjeka N, Garfin AMC, Lomtadze N, Avaliani Z, Kiria N, Malhotra S, Cook-Scalise S, Juneja S, Everitt D, Spigelman M, Vassall A.   +13 more
europepmc   +1 more source